Patient Groups and CSOs in Asia written a letter to Indian Government to Request Waiver on Local Clinical Trial for The Coming Generic DAAs

Patient Groups and CSOs in Asia written a letter to Indian Government to Request Waiver on Local Clinical Trial for The Coming Generic DAAs

Numbers of patient groups and CSOs working on Hepatitis C in Asia requested Indian Government to issue a waiver for requirement to have clinical trial on the coming generic DAAs as they had done during Sofosbuvir registration process back in December 2014, click here to read the full letter.

/ News

Share the Post